Suppr超能文献

产单链抗体片段乳酸菌原位保护胃肠道免受炭疽水肿毒素侵害

In situ gastrointestinal protection against anthrax edema toxin by single-chain antibody fragment producing lactobacilli.

机构信息

Division of Clinical Immunology and Transfusion Medicine, Department of Laboratory Medicine, Karolinska Institutet at Karolinska University Hospital Huddinge, SE-141 86 Stockholm, Sweden.

出版信息

BMC Biotechnol. 2011 Dec 20;11:126. doi: 10.1186/1472-6750-11-126.

Abstract

BACKGROUND

Anthrax is caused by the bacterium Bacillus anthracis and is regarded as one of the most prominent bioterrorism threats. Anthrax toxicity is induced by the tripartite toxin complex, composed of the receptor-binding anthrax protective antigen and the two enzymatic subunits, lethal factor and edema factor. Recombinant lactobacilli have previously been used to deliver antibody fragments directed against surface epitopes of a variety of pathogens, including Streptococcus mutans, Porphyromonas gingivalis, and rotavirus. Here, we addressed whether or not anthrax toxins could be targeted and neutralised in the gastrointestinal tract by lactobacilli producing recombinant antibody fragments as a model system for toxin neutralisation in the gastrointestinal lumen.

RESULTS

The neutralising anti-PA scFv, 1H, was expressed in L. paracasei as a secreted protein, a cell wall-anchored protein or both secreted and wall-anchored protein. Cell wall display on lactobacilli and PA binding of the anchored constructs was confirmed by flow cytometry analysis. Binding of secreted or attached scFv produced by lactobacilli to PA were verified by ELISA. Both construct were able to protect macrophages in an in vitro cytotoxicity assay. Finally, lactobacilli producing the cell wall attached scFv were able to neutralise the activity of anthrax edema toxin in the GI tract of mice, in vivo.

CONCLUSION

We have developed lactobacilli expressing a neutralising scFv fragment against the PA antigen of the anthrax toxin, which can provide protection against anthrax toxins both in vitro and in vivo. Utilising engineered lactobacilli therapeutically for neutralising toxins in the gastrointestinal tract can potential be expanded to provide protection against a range of additional gastrointestinal pathogens. The ability of lactobacilli to colonise the gastrointestinal tract may allow the system to be used both prophylactically and therapeutically.

摘要

背景

炭疽是由炭疽杆菌引起的,被认为是最突出的生物恐怖威胁之一。炭疽毒素的毒性是由三部分毒素复合物诱导的,该复合物由受体结合炭疽保护抗原和两个酶亚基组成,即致死因子和水肿因子。重组乳杆菌以前曾被用于递送针对多种病原体表面表位的抗体片段,包括变形链球菌、牙龈卟啉单胞菌和轮状病毒。在这里,我们研究了产重组抗体片段的乳杆菌是否可以作为胃肠道内毒素中和的模型系统,靶向和中和胃肠道中的炭疽毒素。

结果

中和性抗 PA scFv,1H,在 L. paracasei 中作为分泌蛋白、细胞壁锚定蛋白或分泌和细胞壁锚定蛋白的混合物表达。通过流式细胞术分析证实了乳杆菌上的细胞壁展示和锚定构建体与 PA 的结合。通过 ELISA 验证了乳杆菌产生的分泌或附着 scFv 与 PA 的结合。两种构建体都能够在体外细胞毒性测定中保护巨噬细胞。最后,产细胞壁附着 scFv 的乳杆菌能够在体内中和小鼠胃肠道中的炭疽水肿毒素的活性。

结论

我们开发了表达针对炭疽毒素 PA 抗原的中和 scFv 片段的乳杆菌,该片段能够在体外和体内提供针对炭疽毒素的保护。利用工程乳杆菌在胃肠道中中和毒素可以扩展到提供针对一系列其他胃肠道病原体的保护。乳杆菌定植胃肠道的能力可能允许该系统既可以预防性使用也可以治疗性使用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0800/3295704/56904af9f2c6/1472-6750-11-126-1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验